Is the revised International staging system for myeloma valid in a real world population?

被引：10
|
作者：
Walker, Ieuan [1 ]
Coady, Alice [1 ]
Neat, Michael [2 ,3 ]
Ladon, Darius [4 ]
Benjamin, Reuben [5 ,6 ]
El-Najjar, Inas [2 ,5 ]
Kazmi, Majid [2 ,5 ]
Schey, Steve [5 ,6 ]
Streetly, Matthew [2 ,5 ,6 ]
机构：
[1] Kings Coll London, Guys Kings & St Thomas Sch Med, London, England
[2] NHS, Guys & St Thomas Hosp Trust, Dept Haematol, London, England
[3] NHS, Guys & St Thomas Hosp Trust, Dept Canc Genet, ViaPath, London, England
[4] Kings Coll Hosp London, Dept Cytogenet, Viapath, London, England
[5] Kings Hlth Partners, London, England
[6] Kings Coll Hosp London, Dept Haematol, London, England
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 180卷 / 03期
关键词：
myeloma; prognostic factors; classifications; multiple myeloma; risk factors; MULTIPLE-MYELOMA; WORKING GROUP; SURVIVAL;
D O I：
10.1111/bjh.14341
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：451 / 454
页数：4
相关论文
共 50 条
  • [1] Revised International Staging System Applied to Real World Multiple Myeloma Patients
    Jimenez-Zepeda, Victor H.
    Duggan, Peter
    Neri, Paola
    Rashid-Kolvear, Fariborz
    Tay, Jason
    Bahlis, Nizar J.
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2016, 16 (09): : 511 - 518
  • [2] Real-World Validity of the Revised International Staging System in Multiple Myeloma By Race
    Notardonato, Lucia D.
    Langerman, Spencer S.
    Chiu, Brian C. -H.
    Derman, Benjamin A.
    [J]. BLOOD, 2020, 136
  • [3] Is the Second Revision of the International Staging System (R2-ISS) for Multiple Myeloma Valid in a Real-World Population from China?
    Yan, Wenqiang
    Li, Lingna
    Fan, Huishou
    Xu, Jingyu
    Deng, Shuhui
    Sui, Weiwei
    Xu, Yan
    Zou, Dehui
    Qiu, Lugui
    An, Gang
    [J]. BLOOD, 2022, 140 : 7255 - 7256
  • [4] Validation of the second revision of the international staging system in a real-world myeloma population: a myeloma and related diseases registry study
    Tan, Joanne
    Wellard, Cameron
    Moore, Elizabeth
    Spencer, Andrew
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S124 - S124
  • [5] PROGNOSTIC SIGNIFICANCE OF THE REVISED INTERNATIONAL STAGING SYSTEM IN MULTIPLE MYELOMA
    Sretenovic, A.
    Bila, J.
    Jelicic, J.
    Fekete, M. Dencic
    Djurasinovic, V.
    Smiljanic, M.
    Vukovic, V.
    Antic, D.
    Andjelic, B.
    Todorovic, M.
    Mihaljevic, B.
    [J]. HAEMATOLOGICA, 2016, 101 : 545 - 546
  • [6] Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group
    Palumbo, Antonio
    Avet-Loiseau, Herve
    Oliva, Stefania
    Lokhorst, Henk M.
    Goldschmidt, Hartmut
    Rosinol, Laura
    Richardson, Paul
    Caltagirone, Simona
    Jose Lahuerta, Juan
    Facon, Thierry
    Bringhen, Sara
    Gay, Francesca
    Attal, Michel
    Passera, Roberto
    Spencer, Andrew
    Offidani, Massimo
    Kumar, Shaji
    Musto, Pellegrino
    Lonial, Sagar
    Petrucci, Maria T.
    Orlowski, Robert Z.
    Zamagni, Elena
    Morgan, Gareth
    Dimopoulos, Meletios A.
    Durie, Brian G. M.
    Anderson, Kenneth C.
    Sonneveld, Pieter
    San Miguel, Jesus
    Cavo, Michele
    Rajkumar, S. Vincent
    Moreau, Philippe
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (26) : 2863 - +
  • [7] PROGNOSTIC IMPACT OF THE INTERNATIONAL STAGING SYSTEM (ISS) AND REVISED-ISS (R-ISS) IN 115 PATIENTS WITH MULTIPLE MYELOMA IN THE REAL WORLD
    Cabanas Perianes, V
    Villarrubia, B.
    Moya Arnao, M.
    Moreno Belmonte, M. J.
    Martinez Marin, A.
    Fernandez Poveda, E.
    Sanchez Salinas, A.
    Blanquer Blanquer, M.
    Navarro Almenzar, B.
    Martinez Garcia, A. B.
    Melero Amor, A.
    Berenguer Piqueras, M.
    Perez Lopez, R.
    Salido Fierrez, E.
    Monserrat Coll, J.
    Garcia Hernandez, A. M.
    Cerezo Manchado, J. J.
    Garcia Candel, F.
    Marco, P.
    Moraleda Jimenez, J. M.
    [J]. HAEMATOLOGICA, 2017, 102 : 108 - 109
  • [8] VALIDATION OF REVISED INTERNATIONAL STAGING SYSTEM (R-ISS) IN THE ERA OF NOVEL AGENTS: REAL-WORLD DATA ON 481 MYELOMA PATIENTS FROM A GREEK MYELOMA CENTER
    Giannopoulou, E.
    Terpos, E.
    Konstantinidou, P.
    Verrou, E.
    Papadaki, S.
    Palaska, V.
    Gerofotis, A.
    Karampatzakis, N.
    Kokoviadou, K.
    Markala, D.
    Gagkos, E.
    Batsis, I.
    Anagnostopoulos, A.
    Katodritou, E.
    [J]. HAEMATOLOGICA, 2016, 101 : 782 - 782
  • [9] Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma
    Kastritis, Efstathios
    Terpos, Evangelos
    Roussou, Maria
    Gavriatopoulou, Maria
    Migkou, Magdalini
    Eleutherakis-Papaiakovou, Evangelos
    Fotiou, Despoina
    Ziogas, Dimitrios
    Panagiotidis, Ioannis
    Kafantari, Eftychia
    Giannouli, Stavroula
    Zomas, Athanasios
    Konstantopoulos, Konstantinos
    Dimopoulos, Meletios A.
    [J]. HAEMATOLOGICA, 2017, 102 (03) : 593 - 599
  • [10] Evaluation of Revised International Staging System for Transplant-Eligible Multiple Myeloma Patients
    Gonzalez-Calle, Veronica
    Slack, Abigail
    Luft, Susan
    Pearce, Kathryn
    Ketterling, Rhett P.
    Jain, Tania
    Chirackal, Sinto Sebastian
    Reeder, Craig B.
    Mikhael, Joseph
    Bergsagel, Leif
    Noel, Pierre
    Mayo, Angela
    Slack, James L.
    Adams, Roberta H.
    Ahmann, Gregory
    Braggio, Esteban
    Stewart, Keith
    Van Wier, Scott
    Fonseca, Rafael
    [J]. BLOOD, 2016, 128 (22)
12345